Thromb Haemost 1980; 44(03): 115-118
DOI: 10.1055/s-0038-1650099
Original Article
Schattauer GmbH Stuttgart

Acquired von Willebrand’s Syndrome in the Course of Waldenström’s Disease

Authors

  • Claudine Mazurier

    The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
  • Armelle Parquet-Gernez

    The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
  • Jacques Descamps

    The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
  • Francis Bauters

    The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
  • Maurice Goudemand

    The Laboratoire d'Hémostase, Centre Régional de Transfusion Sanguine, Lille, France
Further Information

Publication History

Received 02 April 1980

Accepted 19 September 1980

Publication Date:
26 July 2018 (online)

Preview

Summary

Acquired von Willebrand's syndrome with a regressive evolution is described in a 66 year old man with Waldenström's disease. An inhibitor electively directed against Ristocetin cofactor activity has been demonstrated, active in vitro after incubation at 37° C. Serum fractionation showed that the inhibitor was independant of the monoclonal IgM and subsequent purification that it was IgG in nature. The results permit its classification as an auto-antibody.